13D Filing: OrbiMed Advisors and Clementia Pharmaceuticals Inc (CMTA)

Page 2 of 12 – SEC Filing

CUSIP No. 185575107
1
NAME OF REPORTING PERSON

OrbiMed Advisors LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
(b)
3
SEC USE ONLY
4
SOURCE OF FUNDS

N/A
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware
NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
7
SOLE VOTING POWER

0
8
SHARED VOTING POWER

10,425,225
9
SOLE DISPOSITIVE POWER

0
10
SHARED DISPOSITIVE POWER

10,425,225
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

10,425,225
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

32.87%*
14
TYPE OF REPORTING PERSON (See Instructions)

IA




* This percentage is calculated based upon 31,717,584  Common Shares (as defined below) of the Issuer outstanding, as set forth in the Issuer’s Form 6-K filed with the Securities and Exchange Commission on August 21, 2017.
Follow Clementia Pharmaceuticals Inc.